Wind Point Partners and New Mountain Capital have formed a joint partnership to acquire Ascensus Specialties, a leader in specialty materials for life sciences, enhancing its growth potential through strategic capital investment.

Target Information

Ascensus Specialties, based in the United States, is a leading provider of specialty materials crucial for various life sciences and specialty markets. The company excels in producing chemicals such as borohydride, borane, and specialty alcoholates, making it a significant player in the high-purity chemical industry. Ascensus was previously owned by a fund managed by Wind Point Partners since 2018, which has enabled its growth through strategic acquisitions, including former specialty chemical businesses from Dow Chemical and BASF.

In recent developments, Ascensus expanded its portfolio by acquiring Strem Chemicals in April 2021. This acquisition reinforces its position in the market, particularly in manufacturing high-purity, research-grade active pharmaceutical ingredients (APIs) and cGMP materials. With its continual focus on customer reliability, Ascensus has achieved double-digit organic growth, serving critical sectors in North America, Europe, and Asia.

Industry Overview in the U.S.

The specialty chemicals industry in the United States is a rapidly evolving sector, characterized by innovation and a growing demand for high-purity materials, particularly in the life sciences. This industry e